Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
14NOV

UK and France sign science pact

3 min read
18:53UTC

Liz Kendall signed the UK-France Strategic Biomedical Alliance on 29 May, the first bilateral science deal of its kind since Brexit, linking Bristol's Isambard-AI supercomputer to France's GENCI.

TechnologyDeveloping
Key takeaway

Shared UK-France compute and researcher mobility rebuild the base layer that feeds founders a decade out.

Science Secretary Liz Kendall signed the UK-France Strategic Biomedical Alliance in Health and AI on Friday 29 May, the first bilateral science deal of its kind since Brexit⁠1. The UK committed £894,000 to a supercomputing partnership linking Bristol's Isambard-AI, a UK National AI Supercomputer, with France's GENCI (Grand Equipement National de Calcul Intensif), the French national high-performance computing agency. A separate fund puts £300,000 a year from the UK alongside €330,000 from France into early-career researcher mobility⁠2. Named partners include the University of Oxford, Universite Paris Cite, the Institut Pasteur, Imperial College London and France's national research agency, the CNRS (Centre National de la Recherche Scientifique), working on women's health, drug-resistant infections, malaria and emerging viruses.

The practical effect of the compute link is that UK biomedical AI researchers gain access to French capacity, and French Teams to British, years before any of that work could spin out into a company. Researcher mobility funding partially reopens the EU talent pipeline that Brexit constrained, letting early-career scientists move between the two systems on funded placements rather than visas and grant applications.

This is the research-infrastructure floor beneath the startup economy, the layer that feeds the spinout pipeline long before any Series A. It follows the same instrument logic as the £2bn quantum commitment that anchored ProQure earlier in the topic: a targeted state cheque into shared infrastructure rather than into individual firms. The sums look small against a major venture round, but shared compute and funded mobility are what produce the founders who raise those rounds a decade later. the Alliance also sidesteps the multilateral negotiation that UK association to Horizon Europe required in 2024, operating as a narrower bilateral instrument below the threshold of a formal UK-EU framework.

Deep Analysis

In plain English

When the UK left the European Union (Brexit), it also left joint European science programmes. Researchers who previously moved freely between UK and EU universities to work on shared projects suddenly faced visa requirements, funding eligibility changes, and restrictions on using shared European research infrastructure. Supercomputers are extremely powerful machines used to model complex biological systems, simulate drug interactions, and analyse large patient datasets. Building one costs hundreds of millions of pounds; most countries operate just one or two national facilities. Countries share access so that researchers can use national machines they could not afford to build independently. The UK-France deal links two national supercomputers: Isambard-AI (based in Bristol) and GENCI (Grand Equipement National de Calcul Intensif, France's national facility). British researchers gain French computing power; French researchers gain access to Isambard-AI. A separate fund pays for early-career researchers to spend time in each other's universities, rebuilding the scientific relationships Brexit disrupted. Named research areas include drug-resistant infections, malaria, women's health and emerging viruses.

Deep Analysis
Root Causes

Brexit created two compounding deficits in UK biomedical research: access to European research infrastructure (particularly HPC compute that underlies large-scale biological modelling) and researcher mobility across EU borders. Both deficits are structural rather than temporary; they persist even after Horizon re-association because Horizon covers grants but not compute-sharing or bilateral secondment outside EU programmes.

the Alliance's £894,000 Isambard-AI / GENCI link is small but fills a specific gap: UK biomedical AI researchers working on population-scale genomic data and drug-discovery modelling need supercomputing hours they cannot purchase commercially without grant funding.

GENCI access via the bilateral agreement gives them a path to French national compute without requiring a full Horizon fellowship application. The researcher-mobility fund similarly targets early-career researchers who would previously have used Erasmus+ and now have no equivalent programme.

What could happen next?
  • Precedent

    A replicable bilateral below-threshold science instrument that bypasses multilateral EU-framework negotiation; the France deal creates a template for similar agreements with Germany, the Netherlands and Sweden without requiring a full UK-EU science framework.

  • Consequence

    The Isambard-AI / GENCI link lowers entry cost for UK biomedical AI research that later spins out into commercial companies, partially rebuilding the pre-Brexit compute-access pipeline that fed spinout formation.

First Reported In

Update #6 · Orbital's $50m has no UK lead

GOV.UK / DSIT· 29 May 2026
Read original →
Different Perspectives
Association of Investment Companies (Richard Stone)
Association of Investment Companies (Richard Stone)
The trust industry body criticised the Budget for leaving Venture Capital Trust relief at 20%. It had lobbied for the 30% rate to return.
Tax Justice UK
Tax Justice UK
The campaign group opposed the 10% founders' rate as a giveaway to a small group of wealthy owners. It said the BADR cut should have gone further, to abolition.
techUK
techUK
The trade body set the new relief against the BADR cut, which halves the most a seller can save to £30,000. It says the Budget takes back with BADR part of what it gives founders.
Startup Coalition
Startup Coalition
The founder lobby group welcomed the Budget package for startups. It treats the new relief as the strongest government support for founders in years.
HM Treasury
HM Treasury
The Treasury created a 10% founders' relief on up to £10m of lifetime gains and expects about 600 people a year to use it. It says the relief rewards founders behind the UK's fastest-growing companies.
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.